{"count": 4, "results": [{"_id": "33617679", "pmid": 33617679, "title": "The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.", "journal": "Int J Clin Pract", "authors": ["Abdel Monem MS", "Farid SF", "Abbassi MM", "Youssry I", "Andraues NG", "Hassany M", "Selim YMM", "El-Sayed MH"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/ijcp.14104", "meta_date_publication": "2021 Jun", "meta_volume": "75", "meta_issue": "6", "meta_pages": "e14104", "score": 50257.57, "text_hl": "Both groups were receiving @<m>DISEASE_beta_Thalassemia</m> @DISEASE_MESH:D017086 @@@beta-TM@@@ standard-of-care regimen, whereas @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (500 mg, twice daily) was added to the treatment group's regimen only. ", "citations": {"NLM": "Abdel Monem MS, Farid SF, Abbassi MM, Youssry I, Andraues NG, Hassany M, Selim YMM, El-Sayed MH. The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial. Int J Clin Pract. 2021 Jun;75(6):e14104. PMID: 33617679", "BibTeX": "@article{33617679, title={The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.}, author={Abdel Monem MS and Farid SF and Abbassi MM and Youssry I and Andraues NG and Hassany M and Selim YMM and El-Sayed MH}, journal={Int J Clin Pract}, volume={75}, number={6}, pages={e14104}}"}}, {"_id": "39317887", "pmid": 39317887, "title": "Combination Therapy with Vitamin D and Metformin: A Potential Approach to Mitigate Testicular Dysfunction in Type 2 Diabetes Mellitus.", "journal": "Reprod Sci", "authors": ["Odetayo AF", "Abdulrahim HA", "Yusuf AM", "Aromokhame WO", "Olaitan AM", "Ugoji MC", "Hamed MA", "Olayaki LA"], "date": "2024-09-25T00:00:00Z", "doi": "10.1007/s43032-024-01708-3", "meta_date_publication": "2024 Sep 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50243.74, "text_hl": "However, recent findings have associated long-term @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intake with progressive oxidative pancreatic @<m>DISEASE_beta_Thalassemia</m> @DISEASE_MESH:D017086 @@@beta@@@ cell damage as the disease progresses. ", "citations": {"NLM": "Odetayo AF, Abdulrahim HA, Yusuf AM, Aromokhame WO, Olaitan AM, Ugoji MC, Hamed MA, Olayaki LA. Combination Therapy with Vitamin D and Metformin: A Potential Approach to Mitigate Testicular Dysfunction in Type 2 Diabetes Mellitus. Reprod Sci. 2024 Sep 25;():. PMID: 39317887", "BibTeX": "@article{39317887, title={Combination Therapy with Vitamin D and Metformin: A Potential Approach to Mitigate Testicular Dysfunction in Type 2 Diabetes Mellitus.}, author={Odetayo AF and Abdulrahim HA and Yusuf AM and Aromokhame WO and Olaitan AM and Ugoji MC and Hamed MA and Olayaki LA}, journal={Reprod Sci}}"}}, {"_id": "36118716", "pmid": 36118716, "pmcid": "PMC9473365", "title": "Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis", "journal": "Open Vet J", "authors": ["Kellon EM", "Gustafson KM"], "date": "2022-07-01T00:00:00Z", "doi": "10.5455/OVJ.2022.v12.i4.14", "meta_date_publication": "2022 Jul-Aug", "meta_volume": "12", "meta_issue": "4", "meta_pages": "511-518", "score": 50242.05, "text_hl": "Ten @SPECIES_9796 @@@horses@@@ with @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyperinsulinemia@@@ refractory to diet control, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Thyroxine @CHEMICAL_MESH:D013974 @@@levothyroxine@@@, and @CHEMICAL_Pergolide @CHEMICAL_MESH:D010479 @@@pergolide@@@ (if diagnosed with @<m>DISEASE_beta_Thalassemia</m> @DISEASE_MESH:D017086 @@@PPID@@@) were treated with sodium-glucose cotransporter-2 inhibitor @CHEMICAL_Canagliflozin @CHEMICAL_MESH:D000068896 @@@canagliflozin@@@ (Invokana ). ", "citations": {"NLM": "Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis Open Vet J. 2022 Jul-Aug;12(4):511-518. PMID: 36118716", "BibTeX": "@article{36118716, title={Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis}, author={Kellon EM and Gustafson KM}, journal={Open Vet J}, volume={12}, number={4}, pages={511-518}}"}}, {"_id": "20415181", "pmid": 20415181, "title": "Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.", "journal": "Tunis Med", "authors": ["Dhouib N", "Turki Z", "Mellouli F", "Ouederni M", "Yahiaoui S", "Nagi S", "Ben Slama C", "Bejaoui M"], "date": "2010-02-01T00:00:00Z", "meta_date_publication": "2010 Feb", "meta_volume": "88", "meta_issue": "2", "meta_pages": "136", "score": 50069.49, "text_hl": "Efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ complicating @<m>DISEASE_beta_Thalassemia</m> @DISEASE_MESH:D017086 @@@thalassemia major@@@.", "citations": {"NLM": "Dhouib N, Turki Z, Mellouli F, Ouederni M, Yahiaoui S, Nagi S, Ben Slama C, Bejaoui M. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major. Tunis Med. 2010 Feb;88(2):136. PMID: 20415181", "BibTeX": "@article{20415181, title={Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.}, author={Dhouib N and Turki Z and Mellouli F and Ouederni M and Yahiaoui S and Nagi S and Ben Slama C and Bejaoui M}, journal={Tunis Med}, volume={88}, number={2}, pages={136}}"}}]}